🌍 GRANOLAS: Europe's Darlings
These 11 stocks are Europe's answer to the 'Magnificent 7'
Greetings from San Francisco! 👋🏼
Over 94,000 How They Make Money subscribers turn to us weekly for business and investment insights. Glad you're here.
By now, you are familiar with the Magnificent Seven. Coined in 2023 by BofA analyst Michael Hartnett, this group of American companies includes Microsoft, Apple, NVIDIA, Amazon, Google, Meta, and Tesla.
Last month, someone reached out to me with a great suggestion.
Who are the GRANOLAS? Goldman Sachs coined this acronym in 2020 for a group of 11 European stocks poised for greatness.
These 11 stocks drove 60% of the STOXX Europe 600 index gains in 2023. They dominate their respective industries from the UK to Switzerland and everywhere across the European Union.
Dive into 🌍 GRANOLAS: Europe’s Darlings, exclusively for Premium subscribers. This report visualizes the FY23 performance of these 11 companies. You can download all the visuals in a high-resolution report at the end of the article.
Today at a glance:
💊 Pharma: Novo Nordisk, Roche, Novartis, AstraZeneca, Sanofi, GSK.
☕️ Consumer Staple: Nestlé.
👜 Consumer Discretionary: LVMH and L'Oréal.
🌐 Technology: ASML and SAP.
1. 💊 Pharma
Novo Nordisk
The company reports in Danish Krones (1 DKK = ~€0.13).
Background:
Danish pharmaceutical leader Novo Nordisk has become the largest company in Europe with a market cap of nearly $600 billion, surpassing giants like Visa and Tesla. Their weight-management drugs, Ozempic (diabetes) and Wegovy, have seen explosive demand.
Recent developments:
Supply boost: Novo Nordisk has begun significantly increasing supplies of Wegovy, particularly the lower "starter" doses, in the US. This is a significant step forward after supply shortages limited new patient access in 2023.